Summary of editorials from the Hebrew press
Israeli Missions Around The World Los Angeles Press Room Media Appearances Summary of editorials from the Hebrew press

Summary of editorials from the Hebrew press 4/2

  • 4/2/2015
  •  
     
  •  
  •  
    ​
    The Jerusalem Post commends the Knesset on its solar rooftop initiative, and calls on the government to set nationwide goals and budgeting for similar projects in other government installation. The editor comments that “The government embrace of a green Israel builds on years of environmental awareness in the country that stretches back to innovations even prior to the state,” and concludes that while “The country has made remarkable innovations, such as investing in desalination plants and using recycled waste water for agriculture,” now is the time to take the next step forward in other environmental fields as well.
     
    Haaretz criticizes the newly inaugurated Knesset for immediately taking a recess of no less than a month, and asserts: “all the elected officials would do well in the next term to act to shorten the recesses and bring order to the legislature’s activity.”
     
    Yediot Aharonot comments on the stated intent of US President Barack Obama to reassess his policy on the Palestinian issue, and declares: “The plain truth is that the president identified a real need to perform an in-depth examination because his previous policy to advance the establishment of a Palestinian state alongside Israel had failed.”
     
    Yisrael Hayom discusses the nuclear negotiations with Iran and contends: “Iran came to Lausanne to sell its product at the highest price.” The author reminds his readers that sensing the West’s weakness, Iran hardened its tone and even withdrew some of the concessions it had previously agreed to, and asks: “Since the Iranians know the customer wants an agreement, why should they lower the price?” The author adds: “The Americans cannot return home empty-handed,” and contends that “The Persian bazaar in Lausanne” will continue.
     
    Globes discusses the acquisition of Auspex Pharmaceuticals by Israeli pharmaceutical giant Teva, and notes that this is a significant development in the company’s strategy. The author believes “The acquisition is designed to obtain a given product with potential and also indicates Teva's intention to re-emphasize the innovative aspect of its business,” and adds: “Judging by the potential of the company's technology, the acquisition appears more than suitable for Teva.”
     
    [Efraim Halevy, Boaz Bismuth and Gali Weinrebwrote today's articles in Yediot Aharonot, Yisrael Hayom and Globes, respectively.]​